GORACCI, Gianfrancesco
 Distribuzione geografica
Continente #
NA - Nord America 4.635
EU - Europa 3.062
AS - Asia 2.532
SA - Sud America 375
Continente sconosciuto - Info sul continente non disponibili 210
AF - Africa 56
OC - Oceania 3
AN - Antartide 1
Totale 10.874
Nazione #
US - Stati Uniti d'America 4.510
SG - Singapore 1.161
UA - Ucraina 626
IE - Irlanda 535
SE - Svezia 389
CN - Cina 364
RU - Federazione Russa 337
HK - Hong Kong 321
BR - Brasile 298
IT - Italia 297
DE - Germania 246
FI - Finlandia 179
VN - Vietnam 179
KR - Corea 153
FR - Francia 148
GB - Regno Unito 119
CA - Canada 73
IN - India 65
TR - Turchia 62
BD - Bangladesh 51
BE - Belgio 39
IQ - Iraq 33
PL - Polonia 30
UZ - Uzbekistan 27
AR - Argentina 25
CH - Svizzera 23
MX - Messico 22
NL - Olanda 20
ZA - Sudafrica 18
PK - Pakistan 16
CO - Colombia 15
ES - Italia 14
SA - Arabia Saudita 14
AT - Austria 12
ID - Indonesia 11
PH - Filippine 11
AE - Emirati Arabi Uniti 10
JP - Giappone 10
VE - Venezuela 10
EC - Ecuador 8
GR - Grecia 8
MA - Marocco 8
CL - Cile 7
EG - Egitto 7
JM - Giamaica 7
KZ - Kazakistan 7
CZ - Repubblica Ceca 6
HN - Honduras 6
MY - Malesia 6
TN - Tunisia 6
EU - Europa 5
IL - Israele 5
LT - Lituania 5
AL - Albania 4
DZ - Algeria 4
EE - Estonia 4
LB - Libano 4
OM - Oman 4
PY - Paraguay 4
AZ - Azerbaigian 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
JO - Giordania 3
KE - Kenya 3
PR - Porto Rico 3
RS - Serbia 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BN - Brunei Darussalam 2
HU - Ungheria 2
IM - Isola di Man 2
LV - Lettonia 2
LY - Libia 2
ME - Montenegro 2
NI - Nicaragua 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
PE - Perù 2
PS - Palestinian Territory 2
TH - Thailandia 2
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AU - Australia 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BS - Bahamas 1
BT - Bhutan 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
CR - Costa Rica 1
DK - Danimarca 1
GT - Guatemala 1
IR - Iran 1
KG - Kirghizistan 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
Totale 10.661
Città #
Singapore 760
Chandler 665
Dublin 535
Ashburn 381
San Jose 336
Jacksonville 326
Hong Kong 320
San Mateo 237
Boardman 171
Ann Arbor 165
Seoul 152
Santa Clara 150
Council Bluffs 138
Moscow 118
Medford 111
Princeton 108
Munich 98
Lauterbourg 94
Wilmington 93
Beijing 79
Andover 59
Piscataway 54
Los Angeles 51
New York 47
Dong Ket 45
Ho Chi Minh City 41
São Paulo 40
Des Moines 39
Brussels 38
Izmir 37
Turku 35
Houston 34
Perugia 33
Helsinki 31
Rome 31
Orem 29
Woodbridge 29
Dallas 28
Altamura 26
Saint Petersburg 26
The Dalles 26
Hanoi 25
Montreal 25
Shanghai 25
Frankfurt am Main 22
Auburn Hills 20
Milan 20
Lawrence 19
Norwalk 17
Toronto 17
Brooklyn 16
Chicago 16
Baghdad 15
Denver 15
Falls Church 15
Warsaw 15
Atlanta 14
Tashkent 14
Chennai 12
Johannesburg 11
Belo Horizonte 10
Boston 10
London 10
Stockholm 10
Amsterdam 9
Mexico City 9
Phoenix 9
Rio de Janeiro 9
San Francisco 9
Ankara 8
Città Di Castello 8
Mumbai 8
New Delhi 8
Ottawa 8
Tokyo 8
Betim 7
Brasília 7
Guangzhou 7
Poplar 7
Secaucus 7
Da Nang 6
Dammam 6
Dhaka 6
Ninh Bình 6
Cairo 5
Changsha 5
Charlotte 5
Columbus 5
Espoo 5
Grugliasco 5
Manchester 5
Redwood City 5
Seattle 5
Tianjin 5
Bexley 4
Biên Hòa 4
Busto Arsizio 4
Campinas 4
Carney 4
Cisterna di Latina 4
Totale 6.415
Nome #
L’infiltrazione intradetrusoriale di tossina botulinica A riduce i livelli tissutali vescicali di nerve growth factor in pazienti affetti da iperattività detrusoriale neurogena. 231
Activation of phospholipase A2 and B-thromboglobulin release in human platelets: comparative effects of thrombin and fluoroaluminate stimulation. 189
Activation of human platelet phospholipase A2 induced by phisiological agonist or fluoroaluminate: effec of inhibitors of protein kinases 182
Characterization of nuclear secretory phospholipase A2 (sPLA2) 163
Studio di un'attività fosfolipasica presente nei nuclei di cellule gliali e neuronali di corteccia cerebrale di ratto. 147
Characterization of a phospholipase A2 present in purified nuclei from rat brain cortex . INTERNATIONAL CONFERENCE ON PHOSPHOLIPASE A2 142
Misurazione del PAF (fattore attivante le piastrine) nella saliva umana; standardizzazione del metodo 139
The induction of long-term potentiation (LTP) in the medial vestibular nuclei enhances the activities of enzymes involved in the synthesis of platelet-activating-factor (PAF). 132
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 132
PAF-synthesizing enzyme activities increase during long-term potentiation in the rat medial vestibular nuclei 131
Rat brain release a phospholipase A2 having properties similar those of the typr II secretory enzymes 130
Group II phospholipase A2 (GIIA) is involved in neuritogenesis in NGF-treated PC12 cells. 129
Phospholipase A2 activity in rat brain nuclei. 128
Release of group IIA secretory phospholipase A2 from rat brain mitochondria: does it correlated with that of cytochrome c? 126
EFFECT OF NGF ON PHOSPHOLIPASES A2 LOCALIZATION IN PC12 CELLS 125
Analysis by high performance liquid chromatography of the water-soluble precursors of choline and ethanolamine phosphoglycerides in the rat brain 124
RELEASE OF GROUP IIA SECRETORY PHOSPHOLIPASE A2 FROM RAT BRAIN MITOCHONDRIA: DOES IT CORRELATE WITH THAT OF CYTOCHROME c? 124
The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex. 120
Botulinum A toxin intravesical treatment induces a reduction of nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity. 120
Metabolism and Functions of Platelet-Activating Factor (PAF) in the Nervous Tissue 120
Effect of NGF on the Subcellular Localization of Group IIA Secretory Phospholipase A2 (GIIA) in PC12 Cells: Role in Neuritogenesis. 119
Properties of phospholipase A2 in the nuclear fraction of rat brain cortex 118
Bladder tissue levels of nerve growth factor in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 118
Cloricromene inhibits G-Protein mediated activation of phospholipase A2 in human platelets 117
Localisation and properties of Phospholipases A2 in rat brain cortex mithocondria assayed with labelled E.Coli membranes as substrates. 116
Is isoprostane 8-iso-PGF2a a reliable marker of different velico-sphincter dysfunction? 115
Mitochondrial localization of sPLA2-IIA in neuronal cell 114
Choline plasmalogen biosynthesis by transmethylation in human platelets 113
Botulinum-A toxin injections into the detrusor muscle reduce nerve growth factor bladder tissue levels in patients affected by neurogenic detrusor overactivity. 112
Distribution of secretory phospholipase A2 (PLA2) in neural cells 112
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 111
Role of Platelet activating factor in the long term potentiation of the rat medial vestibular nuclei. 111
Characterization of a Phospholipases A2 present in purified nuclei from brain cortex 111
NGF Induces the Expression of Group IIA Secretory Phospholipase A2 in PC12 Cells: The Newly Synthesized Enzyme Is Addressed to Growing Neurites 111
Fusion of human platelets with cytidine-5-phospate loaded liposomes: effect on arachidonic acid release. 110
Group B streptococcus (GBS) causes macrophage PLA2s activation and modification of phosphatidyl- serine metabolism during induction of apoptosis 108
Down-regulation of fluoroaluminate-induced release of arachidonic acid by protein kinase C is calcium-dependent and not related to secretory phospholipase A2 107
Bladder tissue levels of NGF in SCI patients with detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 107
BOTULINUM-A TOXIN INJECTIONS INTO THE DETRUSOR MUSCLE REDUCE NERVE GROWTH FACTOR BLADDER TISSUE LEVELS IN P A TIENTS AFFECTED BY NEUROGENIC DETRUSOR OVER- ACTIVITY 107
The release of arachidonic acid (AA ) by human platelets stimulated by fluoroaluminate and low concetration of collagene potentiated by inhibitors of protein kinase C (PKC). 106
Brain secretory phospholipase A2: functions and roles in neurodegenerative diseases 106
CHARACTERIZATION OF NUCLEAR SECRETORY PHOSPHOLIPASE A2 (sPLA2) 106
Platelet activating factor : a potential retrograde messenger in long term potentiation of the rat medial vestibular nuclei. 105
Immunolocalization of secretory phospholipases A2 (sPLA2) in neural cells 105
Botulinum A toxin intradetrusorial injections modulate the bladder expression of NGF, TRKA, P75 and TRPV1 in patients with detrusor overactivity. 105
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity 105
Characterization of rat brain phospholipases A2 and their possible role in cellular signaling 104
Platelet-activating factor and group I metabotropic glutamate receptors interact for full development and maintenance of long-term potentiation in the rat medial vestibular nuclei. 104
Brain secreted phospholipases A2 (sPLA2) as intra- and extra-cellular mediators 101
The synthesis of choline and etrhanolamine phosphoglycerides in neuronal and glial cells of rabbit in vitro. 100
Brain mitochondrial phospholipases A2: functions and role in cell death 100
Effect of protein kinase inhibitors on HFS-induced long term potentiation and activation of PAF-synthesizing enzymes in rat medial vestibular nuclei. 100
Nerve Growth Factor bladder tissue levels in patients with benign prostatic hyperplasia and detrusor overactivity treated with tamsulosin. 99
Lipid metabolism during early ischemia 99
High pressure liquid chromatography (HPLC) of water-soluble precursors of choline and ethanolamine phosphoglycerides in animal tissues 99
Brain secretory phospholipases A2: role in neurodegeneration. 98
Determination of nerve growth factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 97
Subcellular localization of secretory phospholipases A2 (sPLA2) group IIA (GIIA) and group V (GV) in neural cells 96
Involvement of group IIA secretory phospholipase A2 (GIIA) in NGF-induced neuritogenesis of PC12 cells 95
Enhancement of PAF-synthesizing enzyme activities during long-term potentiation (LTP) in rat brain-stem slices 94
Cholinephosphotransferase activity in human platelet 94
Mitochondrial and nuclear secretory phospholipases A2: potential partecipation to life or death decision of neural cells. 92
Presence of Group V Phospholipase A2 in rat brain cortex nuclei. 92
Properties of phospholipase A2 in the nuclear fraction of rat brain cortex. European Society of Neurochemistry and International Society of Neurochemistry (ESN-ISN) 91
The metabolism of labelled ethanolamine in neuronal and glial cells of the rabbit in vivo. 91
Is the cytosolic phospholipase A2 the enzyme that is activated by a G- protein-mediated mechanism in human platelets and is down-regulated by protein kinase C ? 91
Presence of Group V Phospholipase A2 in rat brain cortex nuclei 91
The effect of calcium on reactive oxygen species elimination in brain mitochondria 89
Reversible inhibition of hydrogen peroxide elimination by calcium in brain mitochondria 89
The bladder urothelium: passive permeability and intravesical drug passive diffusion. 89
Enzymic synthesis of ethanolamine plasmalogens through ethanolaminephospho-transferase activity in neurons and glial cells of rabbit in vitro 89
The effects of Calcium on reactive oxygen species elimination in brain mitochondria 88
Release of a phospholipase a2 from rat brain mithocondria. 88
Nerve Growth factor bladder tissue levels in patients with neurogenic detrusor overactivity before and after botulinum-A toxin injections into the detrusor muscle 87
Enzymic synthesis of 1-alkyl-2-acyl-sn-glycero-3-phosphorylethanolamine through ethanolaminephosphotransferase activity in the neuronal and glial cells of rabbit in vitro 87
Role of protein kinase C in the release of arachidocic acid from platelets 87
Role of Platelet-Activating Factor in long-term potentiation of the medial vestibular nuclei. 86
Low molecular weight phospholipases A2 in mammalian brain and neural cells: roles in functions and dysfunctions. 86
The presence of a secretory phospholipase A2 in the nuclei of neuronal and glial cells of rat brain cortex 85
Trattamento dei disturbi vescicali sensitivi con tossina botulinica A: studio pilota 84
Protein kinase C inhibitors enhance G-protein induced phospholipase A2 activation in intact human platelets 83
Platelet-activating factor: role in long-term potentiation and in brain damage 82
Secretory phospholipases A2 in neural cells: localization and functions 81
Inhibition of PAF synthesis by stimulated human polymorphonuclear leucocytes with cloricromene, an inhibitor of phospholipase A2 activation 79
Involvment of group IIA phospholipase A2 (GIIA) in NGF-induced neuritogenesis of PC12 cells 77
Livelli tissutali vescicali di Nerve Growth Factor nella Ipertrofia Prostatica Benigna ed iperattività detrusoriale dopo terapia con Tamsulosina. 77
Membrane phosphatidylcholine pools and synthetic mechanisms. 77
Metabolism and functions of phosphatidylserine in mammalian brain. 77
Determination of Nerve Growth Factor levels into human bladder wall by modified enzyme-linked immunoabsorbent assay. 76
Evidence that cytosolic phospholipase A2 is down-regulated by protein kinase C in intact human platelets stimulated with fluoroaluminate. 76
Metabolic studies on ethanolamine phosphoglycerides in neuronal and glial cells. 75
PAF levels in saliva are regulated by inflammatory cells 75
Cloricromene inhibits leukotriene formation by human polymorphonuclear leukocytes by suppressing arachidonate release from membrane phospholipids. 74
Low Molecular Weight Phospholipases A2 in Mammalian Brain and Neural Cells: Roles in Functions and Dysfunctions 73
Livelli tissutali di Nerve growth factor nella ipertrofia prostatica benigna ed iperattività detrusoriale dopo terapia con tamsulosina. 73
Respiratory state and release of mitochondrial phospholipase A2 72
Intracellular functions of low molecular weight phospholipases A2 72
Phospholipase A2 release from rat brain cortex mitochondria depends on respiratory state and precedes the liberation of cytochrome c 71
Rat brain cortex mitochondria release group II secretory phospholipase A(2) under reduced membrane potential. 71
Group IIA secretory phospholipase A2 (GIIA) mediates apoptotic death during NMDA receptor activation in rat primary cortical neurons. 70
Totale 10.382
Categoria #
all - tutte 45.813
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.813


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022714 0 0 0 68 43 12 19 259 12 33 99 169
2022/20231.779 141 203 27 187 136 209 2 100 682 4 61 27
2023/2024669 34 69 31 6 10 9 174 24 91 7 135 79
2024/20251.440 47 178 102 51 193 42 30 105 258 71 228 135
2025/20263.129 242 198 148 442 443 282 501 134 365 257 79 38
2026/2027553 48 90 175 240 0 0 0 0 0 0 0 0
Totale 10.874